Ping An Hong Kong launches healthcare and AI ETFs

Ping An Asset Management (Hong Kong) has launched two exchange-traded funds: the Ping An Healthcare 50 Select ETF and the Ping An AI Select ETF. Both funds track Solactive G2 indices and provide Hong Kong investors with rules-based exposure to companies listed in Hong Kong and the United States.

The Ping An Healthcare 50 Select ETF follows the Solactive G2 Healthcare 50 Select Index. The index applies minimum size and liquidity filters, then selects up to 30 Hong Kong-listed and up to 20 US-listed securities by free-float market capitalisation. Constituents are weighted 62% to Hong Kong listings and 38% to US listings. Individual Hong Kong constituents are capped at 8% and US constituents at 5%. The five largest components together cannot exceed 55% of the index. Hong Kong-listed securities must be eligible for Southbound Trading via the Shanghai-Hong Kong or Shenzhen-Hong Kong Stock Connect. The index is rebalanced quarterly.

The Ping An AI Select ETF tracks the Solactive G2 Artificial Intelligence Select Index. The AI index classifies companies into three segments: AI Infrastructure, AI Platforms and AI Applications. After liquidity screens, eligible securities are ranked by free-float market capitalisation and the index selects up to 20 Hong Kong-listed and up to 40 US-listed companies. The index weight is 62% for Hong Kong-listed constituents and 38% for US-listed constituents, with a 10% cap on each individual security. The AI index is rebalanced quarterly. Solactive says the index reflects developments in semiconductors, data infrastructure, AI platforms and application software across the United States and Asia.

Solactive supplies the index methodologies and quarterly rebalancing schedules, while Ping An Asset Management (Hong Kong) is the ETF issuer. Timo Pfeiffer, Solactive’s chief markets officer, noted the firms deepened their collaboration and highlighted the use of transparent, rules-based index solutions for these sectors. Albert Wang, head of capital markets and chief investment officer at Ping An Asset Management (Hong Kong), described the AI ETF’s coverage of infrastructure, platforms and applications and said the healthcare ETF focuses on Chinese pharmaceutical companies expanding internationally alongside US leaders in innovative medicines.

The funds’ eligibility rules, weighting and constituent caps are set to provide targeted sector exposure while diversifying holdings across markets and company sizes.